187 related articles for article (PubMed ID: 31232159)
1. Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3.
Lv S; Wen H; Shan X; Li J; Wu Y; Yu X; Huang W; Wei Q
Epigenetics; 2019 Dec; 14(12):1194-1208. PubMed ID: 31232159
[TBL] [Abstract][Full Text] [Related]
2. Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4.
Lv S; Ji L; Chen B; Liu S; Lei C; Liu X; Qi X; Wang Y; Lai-Han Leung E; Wang H; Zhang L; Yu X; Liu Z; Wei Q; Lu L
Oncogene; 2018 Mar; 37(10):1354-1368. PubMed ID: 29269867
[TBL] [Abstract][Full Text] [Related]
3. Histone methyltransferase KMT2D promotes prostate cancer progression through paracrine IL-6 signaling.
Zhang J; Ye Y; Xu Z; Luo M; Wu C; Zhang Y; Lv S; Wei Q
Biochem Biophys Res Commun; 2023 May; 655():35-43. PubMed ID: 36924677
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibitors of the prostate cancer target KMT2D.
Yu Q; Liao Z; Liu D; Xie W; Liu Z; Liao G; Wang C
Biochem Biophys Res Commun; 2020 Dec; 533(3):540-547. PubMed ID: 32988590
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer.
Feng Q; He P; Wang Y
Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
[TBL] [Abstract][Full Text] [Related]
6. C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy.
Salcher S; Hermann M; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
Mol Cancer; 2017 May; 16(1):95. PubMed ID: 28545464
[TBL] [Abstract][Full Text] [Related]
7. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression.
Li W; Wu L; Jia H; Lin Z; Zhong R; Li Y; Jiang C; Liu S; Zhou X; Zhang E
Cell Mol Biol Lett; 2021 Nov; 26(1):45. PubMed ID: 34758724
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancer.
Xiong W; Deng Z; Tang Y; Deng Z; Li M
Biochem Biophys Res Commun; 2018 Sep; 504(1):129-136. PubMed ID: 30177394
[TBL] [Abstract][Full Text] [Related]
9. KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
Alam H; Tang M; Maitituoheti M; Dhar SS; Kumar M; Han CY; Ambati CR; Amin SB; Gu B; Chen TY; Lin YH; Chen J; Muller FL; Putluri N; Flores ER; DeMayo FJ; Baseler L; Rai K; Lee MG
Cancer Cell; 2020 Apr; 37(4):599-617.e7. PubMed ID: 32243837
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.
Ding B; Yan L; Zhang Y; Wang Z; Zhang Y; Xia D; Ye Z; Xu H
FEBS Open Bio; 2019 Apr; 9(4):693-706. PubMed ID: 30984543
[TBL] [Abstract][Full Text] [Related]
11. KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation.
Guo C; Chen LH; Huang Y; Chang CC; Wang P; Pirozzi CJ; Qin X; Bao X; Greer PK; McLendon RE; Yan H; Keir ST; Bigner DD; He Y
Oncotarget; 2013 Nov; 4(11):2144-53. PubMed ID: 24240169
[TBL] [Abstract][Full Text] [Related]
12. KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis.
Lin-Shiao E; Lan Y; Coradin M; Anderson A; Donahue G; Simpson CL; Sen P; Saffie R; Busino L; Garcia BA; Berger SL; Capell BC
Genes Dev; 2018 Jan; 32(2):181-193. PubMed ID: 29440247
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
14. Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors.
Morcillo-Garcia S; Noblejas-Lopez MDM; Nieto-Jimenez C; Perez-Peña J; Nuncia-Cantarero M; Győrffy B; Amir E; Pandiella A; Galan-Moya EM; Ocana A
PLoS One; 2019; 14(4):e0209134. PubMed ID: 30990809
[TBL] [Abstract][Full Text] [Related]
15. KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes.
Sun P; Wu T; Sun X; Cui Z; Zhang H; Xia Q; Zhang D
Biomed Pharmacother; 2019 Jul; 115():108924. PubMed ID: 31100540
[TBL] [Abstract][Full Text] [Related]
16. Loss of Function of the Gene Encoding the Histone Methyltransferase KMT2D Leads to Deregulation of Mitochondrial Respiration.
Pacelli C; Adipietro I; Malerba N; Squeo GM; Piccoli C; Amoresano A; Pinto G; Pucci P; Lee JE; Ge K; Capitanio N; Merla G
Cells; 2020 Jul; 9(7):. PubMed ID: 32668765
[No Abstract] [Full Text] [Related]
17. Cysteine depletion sensitizes prostate cancer cells to agents that enhance DNA damage and to immune checkpoint inhibition.
Saha A; Zhao S; Kindall A; Wilder C; Friedman CA; Clark R; Georgiou G; Stone E; Kidane D; DiGiovanni J
J Exp Clin Cancer Res; 2023 May; 42(1):119. PubMed ID: 37170264
[TBL] [Abstract][Full Text] [Related]
18. FOXO3 Transcription Factor Is Essential for Protecting Hematopoietic Stem and Progenitor Cells from Oxidative DNA Damage.
Bigarella CL; Li J; Rimmelé P; Liang R; Sobol RW; Ghaffari S
J Biol Chem; 2017 Feb; 292(7):3005-3015. PubMed ID: 27994057
[TBL] [Abstract][Full Text] [Related]
19. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma.
Maitituoheti M; Keung EZ; Tang M; Yan L; Alam H; Han G; Singh AK; Raman AT; Terranova C; Sarkar S; Orouji E; Amin SB; Sharma S; Williams M; Samant NS; Dhamdhere M; Zheng N; Shah T; Shah A; Axelrad JB; Anvar NE; Lin YH; Jiang S; Chang EQ; Ingram DR; Wang WL; Lazar A; Lee MG; Muller F; Wang L; Ying H; Rai K
Cell Rep; 2020 Oct; 33(3):108293. PubMed ID: 33086062
[TBL] [Abstract][Full Text] [Related]
20. Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines.
Ide H; Lu Y; Yu J; China T; Kumamoto T; Koseki T; Yamaguchi R; Muto S; Horie S
Prostate; 2012 Sep; 72(13):1407-11. PubMed ID: 22290195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]